
Gene arrays are solid supports upon which a collection of gene-specific nucleic acids have been placed at defined locations, either by spotting or direct synthesis. In array analysis, a nucleic acid-containing sample is labeled and then allowed to hybridize with the gene-specific targets on the array. (In the literature, the term "target" can refer to either the nucleic acids attached to the array or the labeled nucleic acid of the sample. In this article, the nucleic acids attached to arrays are called "targets," whereas the labeled nucleic acids comprising the sample are called "probes.") Based on the amount of probe hybridized to each target spot, information is gained about the specific nucleic acid composition of the sample. The major advantage of gene arrays is that they can provide information on thousands of targets in a single experiment.
The global market for Gene Array was estimated to be worth US$ 878.2 million in 2023 and is forecast to a readjusted size of US$ 980.3 million by 2030 with a CAGR of 1.6% during the forecast period 2024-2030
As the microarray technology approaches its maturity, many of the issues of the early microarrays have been already overcome and consequently the micro-arrays of today are adequately robust and reliable. In addition, with the completion of ongoing large-scale studies that are aiming to investigate the clinical correlation and utility of the microarray data.
Future DNA microarrays are expected to be faster to use, smaller, and more accurate. Supporting sub-systems, well matched with the microarray platforms, will be developed and integrated into the complex LOC devices, suitable for POC diagnostics. These LOC devices will play a central role in personalized medicine. Technical issues observed in the early microarray plat-forms are mostly resolved in the current platforms. New discoveries about the human genome, thereby increasing the depth of our knowledge, will initiate new clinical utilities for DNA microarrays. Enjoying all of these developments, the DNA microarray keeps a reasonable share in the fast-growing clinical diagnostic market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Array, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Gene Array by region & country, by Type, and by Application.
The Gene Array market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Array.
Market Segmentation
By Company
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Segment by Type:
Oligonucleotide DNA Chip
Complementary DNA Chip
Segment by Application
Gene Expression
Genotyping
Genome Cytogenetics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Array manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Gene Array in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Gene Array in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Gene Array Product Introduction
1.2 Global Gene Array Market Size Forecast
1.2.1 Global Gene Array Sales Value (2019-2030)
1.2.2 Global Gene Array Sales Volume (2019-2030)
1.2.3 Global Gene Array Sales Price (2019-2030)
1.3 Gene Array Market Trends & Drivers
1.3.1 Gene Array Industry Trends
1.3.2 Gene Array Market Drivers & Opportunity
1.3.3 Gene Array Market Challenges
1.3.4 Gene Array Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Array Players Revenue Ranking (2023)
2.2 Global Gene Array Revenue by Company (2019-2024)
2.3 Global Gene Array Players Sales Volume Ranking (2023)
2.4 Global Gene Array Sales Volume by Company Players (2019-2024)
2.5 Global Gene Array Average Price by Company (2019-2024)
2.6 Key Manufacturers Gene Array Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Gene Array Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Gene Array
2.9 Gene Array Market Competitive Analysis
2.9.1 Gene Array Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Gene Array Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Array as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oligonucleotide DNA Chip
3.1.2 Complementary DNA Chip
3.2 Global Gene Array Sales Value by Type
3.2.1 Global Gene Array Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Array Sales Value, by Type (2019-2030)
3.2.3 Global Gene Array Sales Value, by Type (%) (2019-2030)
3.3 Global Gene Array Sales Volume by Type
3.3.1 Global Gene Array Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Gene Array Sales Volume, by Type (2019-2030)
3.3.3 Global Gene Array Sales Volume, by Type (%) (2019-2030)
3.4 Global Gene Array Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gene Expression
4.1.2 Genotyping
4.1.3 Genome Cytogenetics
4.1.4 Others
4.2 Global Gene Array Sales Value by Application
4.2.1 Global Gene Array Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Array Sales Value, by Application (2019-2030)
4.2.3 Global Gene Array Sales Value, by Application (%) (2019-2030)
4.3 Global Gene Array Sales Volume by Application
4.3.1 Global Gene Array Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Gene Array Sales Volume, by Application (2019-2030)
4.3.3 Global Gene Array Sales Volume, by Application (%) (2019-2030)
4.4 Global Gene Array Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Gene Array Sales Value by Region
5.1.1 Global Gene Array Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Array Sales Value by Region (2019-2024)
5.1.3 Global Gene Array Sales Value by Region (2025-2030)
5.1.4 Global Gene Array Sales Value by Region (%), (2019-2030)
5.2 Global Gene Array Sales Volume by Region
5.2.1 Global Gene Array Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Gene Array Sales Volume by Region (2019-2024)
5.2.3 Global Gene Array Sales Volume by Region (2025-2030)
5.2.4 Global Gene Array Sales Volume by Region (%), (2019-2030)
5.3 Global Gene Array Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Gene Array Sales Value, 2019-2030
5.4.2 North America Gene Array Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Gene Array Sales Value, 2019-2030
5.5.2 Europe Gene Array Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Gene Array Sales Value, 2019-2030
5.6.2 Asia Pacific Gene Array Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Gene Array Sales Value, 2019-2030
5.7.2 South America Gene Array Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Gene Array Sales Value, 2019-2030
5.8.2 Middle East & Africa Gene Array Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Array Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Array Sales Value
6.2.1 Key Countries/Regions Gene Array Sales Value, 2019-2030
6.2.2 Key Countries/Regions Gene Array Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Gene Array Sales Value, 2019-2030
6.3.2 United States Gene Array Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Array Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Array Sales Value, 2019-2030
6.4.2 Europe Gene Array Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Array Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Array Sales Value, 2019-2030
6.5.2 China Gene Array Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Array Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Array Sales Value, 2019-2030
6.6.2 Japan Gene Array Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Array Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Array Sales Value, 2019-2030
6.7.2 South Korea Gene Array Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Array Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Array Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Array Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Array Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Array Sales Value, 2019-2030
6.9.2 India Gene Array Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Array Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumnia
7.1.1 Illumnia Company Information
7.1.2 Illumnia Introduction and Business Overview
7.1.3 Illumnia Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Illumnia Gene Array Product Offerings
7.1.5 Illumnia Recent Development
7.2 Affymetrix
7.2.1 Affymetrix Company Information
7.2.2 Affymetrix Introduction and Business Overview
7.2.3 Affymetrix Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Affymetrix Gene Array Product Offerings
7.2.5 Affymetrix Recent Development
7.3 Agilent
7.3.1 Agilent Company Information
7.3.2 Agilent Introduction and Business Overview
7.3.3 Agilent Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Agilent Gene Array Product Offerings
7.3.5 Agilent Recent Development
7.4 Scienion AG
7.4.1 Scienion AG Company Information
7.4.2 Scienion AG Introduction and Business Overview
7.4.3 Scienion AG Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Scienion AG Gene Array Product Offerings
7.4.5 Scienion AG Recent Development
7.5 Applied Microarrays
7.5.1 Applied Microarrays Company Information
7.5.2 Applied Microarrays Introduction and Business Overview
7.5.3 Applied Microarrays Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Applied Microarrays Gene Array Product Offerings
7.5.5 Applied Microarrays Recent Development
7.6 Arrayit
7.6.1 Arrayit Company Information
7.6.2 Arrayit Introduction and Business Overview
7.6.3 Arrayit Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Arrayit Gene Array Product Offerings
7.6.5 Arrayit Recent Development
7.7 Sengenics
7.7.1 Sengenics Company Information
7.7.2 Sengenics Introduction and Business Overview
7.7.3 Sengenics Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Sengenics Gene Array Product Offerings
7.7.5 Sengenics Recent Development
7.8 Biometrix Technology
7.8.1 Biometrix Technology Company Information
7.8.2 Biometrix Technology Introduction and Business Overview
7.8.3 Biometrix Technology Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Biometrix Technology Gene Array Product Offerings
7.8.5 Biometrix Technology Recent Development
7.9 Savyon Diagnostics
7.9.1 Savyon Diagnostics Company Information
7.9.2 Savyon Diagnostics Introduction and Business Overview
7.9.3 Savyon Diagnostics Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Savyon Diagnostics Gene Array Product Offerings
7.9.5 Savyon Diagnostics Recent Development
7.10 WaferGen
7.10.1 WaferGen Company Information
7.10.2 WaferGen Introduction and Business Overview
7.10.3 WaferGen Gene Array Sales, Revenue and Gross Margin (2019-2024)
7.10.4 WaferGen Gene Array Product Offerings
7.10.5 WaferGen Recent Development
8 Industry Chain Analysis
8.1 Gene Array Industrial Chain
8.2 Gene Array Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Array Sales Model
8.5.2 Sales Channel
8.5.3 Gene Array Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Ìý
Ìý
*If Applicable.
